Zusammenfassung
Die chronische Pankreatitis geht mit einem erhöhten Risiko einher, ein Adenokarzinom des Pankreas zu entwickeln. Bis heute existieren keine etablierten Strategien zur Früherkennung des Pankreaskarzinoms bei Patienten mit chronischer Pankreatitis. Der Grund dafür liegt in der unzureichenden Sensitivität und Spezifität klinischer, bildgebender und serologischer Verfahren zur Diagnostik des Karzinoms in einer chronischen Pankreatitis. Ungeachtet dieser Schwierigkeiten sollten Patienten mit klinischem Verdacht auf ein Pankreaskarzinom sorgfältig und ggf. wiederholt untersucht werden. Der Stellenwert von Screeningmaßnahmen bei Patienten mit chronischer Pankreatitis außerhalb von kontrollierten Studien ist nicht gut belegt. Berichtet wird der Fall eines 51-jährigen Patienten mit einer chronischen Pankreatitis, bei dem sich unter engmaschigen bildgebenden Untersuchungen ein duktales Adenokarzinom des Pankreaskopfes entwickelt hat.
Abstract
Patients with chronic pancreatitis are burdened with an increased risk of developing pancreatic cancer. Strategies or guidelines for the surveillance and early detection of pancreatic adenocarcinoma in patients with chronic pancreatitis are not established, because available clinical, serologic or imaging techniques are still of limited sensitivity and specificity. Despite these limitations do patients with chronic pancreatitis and suspected pancreatic cancer need a careful and sometimes repeated diagnostic work-up. A clear benefit of surveillance programs outside of clinical trials for the early detection of pancreatic cancer has not been demonstrated. A 51-year-old patient with chronic pancreatitis is reported who developed cancer of the pancreatic head while undergoing repeated imaging studies.
Literatur
Lowenfels AB, Maisonneuve P, Cavallini G, et al. Pancreatitis and the risk of pancreatic cancer. International Pancreatitis Study Group. N Engl J Med 1993;328:1433–7.
Lowenfels AB, Maisonneuve P, DiMagno EP, et al. Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst 1997;89:442–6.
de Icaza E, López-Cervantes M, Arredondo A, Robles-Díaz G. Likelihood ratios of clinical, laboratory and image data of pancreatic cancer: Bayesian approach. J Eval Clin Pract 2009;15:62–8.
Whitcomb DC. Genetic predispositions to acute and chronic pancreatitis. Med Clin North Am 2000;84:531–47, vii.
Whitcomb DC. Genetic predisposition to alcoholic chronic pancreatitis. Pancreas 2003;27:321–6.
Comfort MW, Steinberg AG. Pedigree of a family with hereditary chronic relapsing pancreatitis. Gastroenterology 1952;21:54–63.
Whitcomb DC, Gorry MC, Preston RA, et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996;14:141–5.
Simon P, Weiss FU, Sahin-Toth M, et al. Hereditary pancreatitis caused by a novel PRSS1 mutation (Arg-122 -> Cys) that alters autoactivation and autodegradation of cationic trypsinogen. J Biol Chem 2002;277:5404–10.
Ellis I, Lerch MM, Whitcomb DC. Genetic testing for hereditary pancreatitis: guidelines for indications, counselling, consent and privacy issues. Pancreatology 2001;1:405–15.
Ekbom A, McLaughlin JK, Karlsson BM, et al. Pancreatitis and pancreatic cancer: a population-based study. J Natl Cancer Inst 1994;86:625–7.
Howes N, Lerch MM, Greenhalf W, et al., European Registry of Hereditary Pancreatitis and Pancreatic Cancer (EUROPAC). Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol 2004;2:252–61.
Rebours V, Boutron-Ruault MC, Schnee M, et al. Risk of pancreatic adenocarcinoma in patients with hereditary pancreatitis: a national exhaustive series. Am J Gastroenterol 2008;103:111–9.
Lowenfels AB, Maisonneuve P, Whitcomb DC, et al. Cigarette smoking as a risk factor for pancreatic cancer in patients with hereditary pancreatitis. JAMA 2001;286:169–70.
Pannala R, Basu A, Petersen GM, Chari ST. New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol 2009;10:88–95.
Mayerle J, Stier A, Lerch MM, Heidecke CD. [Chronic pancreatitis. Diagnosis and treatment.] Chirurg 2004;75:731–47, quiz 748.
Kelsen DP, Portenoy R, Thaler H, et al. Pain as a predictor of outcome in patients with operable pancreatic carcinoma. Surgery 1997;122:53–9.
Fazel A, Draganov P. Interventional endoscopic ultrasound in pancreatic disease. Curr Gastroenterol Rep 2004;6:104–10.
Midwinter MJ, Beveridge CJ, Wilsdon JB, et al. Correlation between spiral computed tomography, endoscopic ultrasonography and findings at operation in pancreatic and ampullary tumours. Br J Surg 1999;86:189–93.
Agarwal B, Kuehn S, Collins BT. Endoscopic ultrasound after preoperative chemoradiation can help identify patients who benefit maximally after surgical esophageal resection. Am J Gastroenterol 2004;99:1258–66.
Catalano MF, Lahoti S, Geenen JE, Hagan WJ. Prospective evaluation of endoscopic ultrasonography, endoscopic retrograde pancreatography, and secretin test in the diagnosis of chronic pancreatitis. Gastrointest Endosc 1998;48:11–7.
Agarwal B, Abu-Hamda E, Molke KL, et al. Endoscopic ultrasound-guided fine needle aspiration and multidetector spiral CT in the diagnosis of pancreatic cancer. Am J Gastroenterol 2004;99:844–50.
Steinberg W. Chronic pancreatic pain: cut for cure? Am J Gastroenterol 1990;85:1427–8.
Lohr M, Maisonneuve P, Lowenfels AB. K-Ras mutations and benign pancreatic disease. Int J Pancreatol 2000;27:93–103.
Chari ST, Smyrk TC, Levy MJ, et al. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol 2006;4:1010–6, quiz 934.
Pickartz T, Mayerle J, Lerch MM. Autoimmune pancreatitis. Nat Clin Pract Gastroenterol Hepatol 2007;4:314–23.
Pickartz T, Pickartz H, Lochs H, Ockenga J. Overlap syndrome of autoimmune pancreatitis and cholangitis associated with secondary Sjogren's syndrome. Eur J Gastroenterol Hepatol 2004;16:1295–9.
Chari ST, Longnecker DS, Kloppel G. The diagnosis of autoimmune pancreatitis: a Western perspective. Pancreas 2009;38:846–8.
Brand RE, Lerch MM, Rubinstein WS, et al. Advances in counselling and surveillance of patients at risk for pancreatic cancer. Gut 2007;56:1460–9.
Rulyak SJ, Brentnall TA. Inherited pancreatic cancer: improvements in our understanding of genetics and screening. Int J Biochem Cell Biol 2004;36:1386–92.
Canto MI, Goggins M, Hruban RH, et al. Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin Gastroenterol Hepatol 2006;4:766–81, quiz 665.
Langer P, Kann PH, Fendrich V, et al. Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer. Gut 2009;58:1410–8.
Poley JW, Kluijt I, Gouma DJ, et al. The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer. Am J Gastroenterol 2009;104:2175–81.
Choudari CP, Nickl NJ, Fogel E, et al. Hereditary pancreatitis: clinical presentation, ERCP findings, and outcome of endoscopic therapy. Gastrointest Endosc 2002;56:66–71.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pickartz, T., Mayerle, J., Kraft, M. et al. Chronische Pankreatitis als Risikofaktor für ein Pankreaskarzinom – diagnostische Herausforderungen. Med Klin 105, 281–285 (2010). https://doi.org/10.1007/s00063-010-1042-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00063-010-1042-6
Schlüsselwörter:
- Chronische Pankreatitis
- Pankreaskarzinom
- Thorakoskopische Splanchnikektomie
- Früherkennung Pankreaskarzinom
- Risikofaktoren Pankreaskarzinom